Graz, Austria

Wolfgang Kroutil

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Wolfgang Kroutil: Pioneering Innovations in Pharmaceutical Compositions

Introduction: Wolfgang Kroutil, an esteemed inventor hailing from Graz, AT, has left an indelible mark on the world of pharmaceutical compositions with his relentless pursuit of innovation.

Latest Patents: Kroutil's latest patents include an abuse-deterrent pharmaceutical composition featuring a drug with an enzyme-reactive functional group, designed to combat abuse potential effectively. He also developed pharmaceutical compositions incorporating oxycodone and an oxycodone-processing enzyme, ensuring stability under specific conditions.

Career Highlights: With a portfolio boasting 8 patents, Wolfgang Kroutil has showcased his expertise through impactful inventions. Having worked with companies like Evonik Degussa GmbH and G.L. Pharma GmbH, he has made significant contributions to the field of pharmaceuticals.

Collaborations: Throughout his career, Kroutil has collaborated with industry experts such as Kurt Faber and Markus Pötter, further enhancing his innovative capabilities and fostering a culture of teamwork in his inventive endeavors.

Conclusion: Wolfgang Kroutil's dedication to advancing pharmaceutical compositions through innovation serves as a beacon for aspiring inventors worldwide. His visionary approach and collaborative spirit exemplify the essence of pushing boundaries and shaping the future of inventive solutions in the pharmaceutical industry.

I hope this information about Wolfgang Kroutil's impactful contributions to the field of pharmaceutical innovations is enlightening and insightful to you. If you have any further inquiries or need more details, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…